Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation

Neurology

Volumn 53, Issue 8, 1999, Pages 1787-1793

  Simon, D K ^a   Pulst, S M ^b   Sutton, J P ^c   Browne, S E ^d   Beal, M F ^d   Johns, D R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Parkinson's Center   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Heteroplasmy; Leber's hereditary optic neuropathy; Mitochondrial DNA; PD; Progressive external ophthalmoplegia

Indexed keywords

LEVODOPA; MITOCHONDRIAL DNA;

ARTICLE; CELL LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DNA SEQUENCE; DRUG RESPONSE; EXTERNAL OPHTHALMOPLEGIA; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENE MUTATION; HEREDITARY OPTIC ATROPHY; HUMAN; MALE; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL;

EID: 0033544323     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.8.1787     Document Type: Article

References (40)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
2. Kitada T, Asakawa S, Nobutaka H, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
3. Beal MF. Aging, energy, and oxidative stress in neurogenerative diseases. Ann Neurol 1995;38:357-366.
4. Schulz JB, Beal MF. Mitochondrial dysfunction in movement disorders. Curr Opin Neurol 1994;7:333-339.
5. Blin O, Desnuelle C, Rascol O, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125:95-101.
6. Langston JW. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 1996;47:S153-S160.
7. Gu M, Cooper JM, Taanman JW, Schapira AH. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
8. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
9. Swerdlow RH, Parks JK, Wooten GF, Miller SW, Davis RE, Parker WD. As in Parkinson's disease, a bioenergetic defect transfers with mitochondrial DNA of patients with multiple system atrophy. Mov Disord 1997;12:3. Abstract.
10. Parker WD Jr, Swerdlow RH. Mitochondrial dysfunction in idiopathic Parkinson disease. Am J Hum Genet 1998;62:758-762.
11. Bandemann O, Marsden CD, Wood NW. Genetic aspects of Parkinson's disease. Mov Disord 1998;13:203-211.
12. Sutton JP, Pulst SM. Atypical parkinsonism in a family of Portuguese ancestry: absence of CAG repeat expansion in the MJD1 gene. Neurology 1997;19:1285-1290.
13. Johns DR, Hurko O. Preferential amplification and molecular characterization of junction sequences of a pathogenetic deletion in human mitochondrial DNA. Genomics 1989;5:623-628.
14. Sprinzl M, Hartmann T, Weber J, Blank J, Zeidler R. Compilation of tRNA sequences and sequences of tRNA genes. Nucl Acids Res 1989;17(suppl):1-172.
15. Jacobs HT, Elliott DJ, Math VB, Farquharson A. Nucleotide sequence and gene organization of sea urchin mitochondrial DNA. J Mol Biol 1987;202:185-217.
16. Fearnley IM, Walker JE. Conservation of sequences of subunits of mitochondrial complex I and their relationships with other proteins. Biochem Biophys Acta 1992;1140:105-134.
17. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-465.
18. Howell N, McCullough DA, Kubacka I, Halvorson S, Mackey D. The sequence of human mtDNA: the question of errors versus polymorphisms. Am J Hum Genet 1991;88:139-145.
19. Marzuki S, Noer AS, Lertrit P, et al. Normal variants of human mitochondrial DNA and translation products: the building of a reference data base. Hum Genet 1991;88:139-145.
20. Prezant TR, Agapian JV, Fischel-Ghodsian N. Corrections to the human mitochondrial ribosomal RNA sequences. Hum Genet 1994;93:87-88.
21. MITOMAP: Human Mitochondrial Genome Database. Center for Molecular Medicine, Emory University, Atlanta, GA. 1998. http://www.gen.emory.edu/mitomap.html.
22. Goto J, Watanabe M, Ichikawa Y, et al. Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res 1997;28:373-377.
23. Chalmers RM, Brockington M, Howard RS, Lecky BRF, Morgan-Huges RA, Harding AE. Mitochondrial encephalopathy with multiple mitochondrial DNA deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features. J Neurol Sci 1996;143:41-45.
24. Checcarelli N, Prelle A, Moggio M, et al. Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J Neurol Sci 1994;123:74-79.
25. Newman NJ. Leber's hereditary optic neuropathy. Arch Neurol 1993;50:540-548.
26. Brown MD, Voljavec AS, Lott MT, Torroni A, Yang CC, Wallace DC. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 1992;130:163-173.
27. Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 1999;50:111-127.
28. Smith KH, Johns DRJ, Heher KL, Miller NR. Heteroplasmy in Leber's hereditary optic neuropathy. Arch Ophthalmol 1993;111:1486-1490.
29. Hanna MG, Bhatia KP. Movement disorders and mitochondrial dysfunction. Curr Opin Neurol 1997;10:351-356.
30. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43-50.
31. Holt IJ, Harding AE, Morgan-Huges JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.
32. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-311.
33. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-1488.
34. Cock HR, Tabrizi SJ, Cooper JM, Schapira AHV. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy. Ann Neurol 1998; 44:187-193.
35. Parker WD Jr, Oley CA, Parks JK. A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N Engl J Med 1989;320:1331-1333.
36. Smith PR, Cooper JM, Govan GG, Harding AE, Schapira AH. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 1994;122:80-83. lomyopathy. J Neurol Sci 1994;123:74-79.
37. Smith PR, Cooper JM, Govan GG, Harding AE, Schapira AH. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 1994;122:80-83. lomyopathy. J Neurol Sci 1994;123:74-79.
38. Vergani L, Martinuzzi A, Carelli V, et al. mtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochem Biophys Res Commun 1995;210:880-888.
39. Majander A, Finel M, Savontaus M-L, Nikoskelainen E, Wikstrom M. Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy. Eur J Biochem 1996;239:201-207.
40. Carelli V, Ghelli A, Ratta M, et al. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997;48:1623-1632.